Your session is about to expire
← Back to Search
Botox for Migraine
Study Summary
This triallooks at how Botox affects the pain of chronic migraine sufferers, comparing tissues with and without Botox treatment.
- Migraine
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 42 Patients • NCT02321436Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an infection where the injection is supposed to go.You have had bad reactions to Botox in the past.You must be between 18 and 65 years old.Your neurologist has recommended you for surgery to relieve pressure on nerves outside the skull.You have been diagnosed with chronic migraine based on specific criteria and experience consistent neck muscle tenderness.
- Group 1: Botulinum toxin type A injection arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an age criterion for enrollment in this experiment?
"This clinical trial is looking for adult participants aged 18 to 65."
Is it possible for me to participate in this experiment?
"Qualifying individuals for this research must have a diagnosed migraine and be between the legal age of consent and 65 years old. Approximately 49 participants are needed in order to complete this study."
To what afflictions is Botulinum toxin type A injection arm typically administered?
"Botulinum toxin type A injection is a common therapeutic intervention for urinary incontinence, along with spinal cord injury, botox injections and overactive bladder syndrome (oabs)."
Has the FDA endorsed Botulinum toxin type A injection arm?
"As this therapy has already been approved, we can confidently rate the safety of Botulinum toxin type A injection arm as a 3 on our scale."
To what extent has Botulinum toxin type A injection arm been evaluated in prior clinical trials?
"Currently, there are 59 active medical studies examining Botulinum toxin type A injection arm with 19 trials in the advanced Phase 3. Out of all these locations, Farmington Hills Michigan is home to a few such experiments while 726 other clinical trial sites offer this treatment option."
Are there currently any open positions for participants in this research?
"According to clinicaltrials.gov, this experiment is no longer seeking participants as its posting dates range from December 1st 2017 to the fifth of December 2022. However, there are currently 234 other trials recruiting patients at present time."
How extensive is the participation in this clinical experiment?
"As of the most recent update on December 5th 2022, this particular trial is not recruiting. However, if you are interested in participating in a medical study there are 175 trials focused on migraine and 59 studies on Botulinum toxin type A injection currently searching for volunteers."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger